Tumour dormancy: findings and hypotheses from clinical research on breast cancer.
暂无分享,去创建一个
[1] M. von Knebel Doeberitz,et al. Detection and clinical relevance of micrometastatic cancer cells , 2000, Current opinion in oncology.
[2] Lars Holmgren,et al. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma , 1994, Cell.
[3] C. Fearns,et al. Unusual growth characteristics of human melanoma xenografts in the nude mouse: a model for desmoplasia, dormancy and progression. , 1992, British Journal of Cancer.
[4] W. Hrushesky,et al. Menstrual Timing of Breast Cancer Surgery 12 , 1998 .
[5] G. Hortobagyi. High-dose chemotherapy for primary breast cancer: facts versus anecdotes. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] J. Izbicki,et al. Differential expression of proliferation-associated molecules in individual micrometastatic carcinoma cells. , 1993, Journal of the National Cancer Institute.
[7] J. Birkbeck. Meat and cancer , 1991, The Lancet.
[8] R. Scheuermann,et al. Cancer dormancy: Opportunities for new therapeutic approaches , 1997, Nature Medicine.
[9] D J Ferguson,et al. Dormancy of mammary carcinoma after mastectomy. , 1999, Journal of the National Cancer Institute.
[10] E. Copson,et al. Herceptin (trastuzamab) in advanced breast cancer. , 2000, Cancer treatment reviews.
[11] R. Demicheli,et al. Does surgery modify growth kinetics of breast cancer micrometastases? , 2001, British Journal of Cancer.
[12] T. P. Pretlow,et al. Development of micrometastases: earliest events detected with bacterial lacZ gene-tagged tumor cells. , 1990, Journal of the National Cancer Institute.
[13] S. Gruber,et al. MENSTRUAL INFLUENCE ON SURGICAL CURE OF BREAST CANCER , 1989, The Lancet.
[14] I. Fidler,et al. The biology of tumor metastasis. , 1989, Seminars in oncology.
[15] A. Schätzlein,et al. Tumour vasculature as a target for anticancer therapy. , 2000, Cancer treatment reviews.
[16] G. Nicolson,et al. Molecular mechanisms of cancer metastasis: tumor and host properties and the role of oncogenes and suppressor genes , 1991, Current opinion in oncology.
[17] J. Crowe,et al. Local-regional breast cancer recurrence following mastectomy. , 1991, Archives of surgery.
[18] P. Drew,et al. Vascular endothelial growth factor in premenopausal women--indicator of the best time for breast cancer surgery? , 1998, British Journal of Cancer.
[19] Lars Holmgren,et al. Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression , 1995, Nature Medicine.
[20] N Gunduz,et al. Presence of a growth-stimulating factor in serum following primary tumor removal in mice. , 1989, Cancer research.
[21] B. Lord,et al. Growth Kinetics of Tumours , 1978, British Journal of Cancer.
[22] K. Woo,et al. Growth kinetics of small cell carcinoma of the lung. , 1981, European journal of cancer & clinical oncology.
[23] R. Demicheli,et al. Estimate of tumor growth time for breast cancer local recurrences: rapid growth after wake-up? , 1998, Breast Cancer Research and Treatment.
[24] M. Zelen,et al. Prolonged disease-free survival after one course of perioperative adjuvant chemotherapy for node-negative breast cancer. , 1989, The New England journal of medicine.
[25] H Schipper,et al. Shifting the cancer paradigm: must we kill to cure? , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[26] J. Spratt,et al. Rates of Growth of Pulmonary Metastases and Host Survival , 1964, Annals of surgery.
[27] J. Folkman. What is the evidence that tumors are angiogenesis dependent? , 1990, Journal of the National Cancer Institute.
[28] R. Demicheli,et al. Re: Dormancy of mammary carcinoma after mastectomy. , 2000, Journal of the National Cancer Institute.
[29] J. Holland,et al. Surgical adjuvant chemotherapy. , 1977, Annual review of medicine.
[30] N Gunduz,et al. Effect of surgical removal on the growth and kinetics of residual tumor. , 1979, Cancer research.
[31] S. Koscielny,et al. Re: Local recurrences following mastectomy: support for the concept of tumor dormancy. , 1994, Journal of the National Cancer Institute.
[32] J. Uhr,et al. Cancer dormancy: studies of the murine BCL1 lymphoma. , 1991, Cancer research.
[33] G. Bonadonna,et al. Salvage treatments in relapsing resectable breast cancer. , 1989, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.
[34] R. Nissen-Meyer,et al. Surgical adjuvant chemotherapy. Results with one short course with cyclophosphamide after mastectomy for breast cancer , 1978, Cancer.
[35] C. Cornelisse,et al. A prolactin-dependent, metastasising rat mammary carcinoma as a model for endocrine-related tumour dormancy. , 1991, British Journal of Cancer.
[36] Laird Ak. Dynamics of Tumour Growth , 1964 .
[37] S. Salmon,et al. Kinetics of tumor growth and regression in IgG multiple myeloma. , 1972, The Journal of clinical investigation.
[38] G. Hortobagyi,et al. Long-term follow-up of patients with complete remission following combination chemotherapy for metastatic breast cancer. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[39] R. Demicheli,et al. Proposal for a new model of breast cancer metastatic development. , 1997, Annals of oncology : official journal of the European Society for Medical Oncology.
[40] F. Grantham,et al. Role of hormones in the growth and regression of human breast cancer cells (MCF-7) transplanted into athymic nude mice. , 1981, Journal of the National Cancer Institute.
[41] R Foroni,et al. An exponential-Gompertzian description of LoVo cell tumor growth from in vivo and in vitro data. , 1989, Cancer research.
[42] M E Sobel,et al. Metastasis suppressor genes. , 1990, Journal of the National Cancer Institute.
[43] R Demicheli. Growth of testicular neoplasm lung metastases: tumor-specific relation between two Gompertzian parameters. , 1980, European journal of cancer.
[44] Laird Ak. DYNAMICS OF TUMOR GROWTH. , 1964 .
[45] M. Tattersall,et al. Retreating recurrent breast cancer with the same CMF-containing regimen used as adjuvant therapy. The International Breast Cancer Study Group. , 1997, European journal of cancer.
[46] B. Cox. Variation in the effectiveness of breast screening by year of follow-up. , 1997, Journal of the National Cancer Institute. Monographs.
[47] D. Hanahan,et al. Induction of angiogenesis during the transition from hyperplasia to neoplasia , 1989, Nature.